Why the study?
What is the incidence of residual neuromuscular blockade in patients arriving in the recovery room after receiving competitive neuromuscular blocking agents?
Population
100 patients who received a competitive neuromuscular blocking agent during anaesthesia
Design
Cross-sectional, The anaesthetist was not aware that the patient would be…
Follow-up
Immediately on arrival in the recovery room
Authors
Loading...
Bedside tests may miss residual neuromuscular blockade in recovery; leaves open whether quantitative monitoring should be routine.
What is the incidence of residual neuromuscular blockade in patients arriving in the recovery room after receiving competitive neuromuscular blocking agents?
A significant proportion of patients arrive in the recovery room with residual neuromuscular blockade that is not reliably detected by clinical bedside tests.
Beemer et al. (1986) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: